Search - tctmd.com

Displaying 1 - 20 of 259

Sort: Relevancy | Date

News Daily News

Periprocedural MI Signals Worse Outcomes in Stented NSTE ACS Patients: MATRIX

Michael O'Riordan

January 15, 2026

News Conference News AHA 2025

Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI

Todd Neale

November 09, 2025

News Conference News ESC 2025

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

Michael O'Riordan

August 31, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Conference News EuroPCR 2025

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Yael L. Maxwell

June 02, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

News Daily News

The ‘Smoker’s Paradox’ Takes a New Hit From Long-term Analysis

Yael L. Maxwell

March 24, 2025

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

L.A. McKeown

November 06, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

News Conference News EuroPCR 2024

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Michael O'Riordan

May 14, 2024

News Conference News SCAI 2024

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

L.A. McKeown

May 10, 2024

News Daily News

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Michael O'Riordan

March 26, 2024

News Daily News

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

Michael O'Riordan

March 14, 2024

News Conference News TCT 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

L.A. McKeown

October 31, 2023

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Daily News

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Michael O'Riordan

July 18, 2023

News Conference News LINC 2023

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

L.A. McKeown

June 21, 2023

News Conference News LINC 2023

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

L.A. McKeown

June 09, 2023

News Daily News

Enough PCI ‘Versus’ CABG—Time to Focus on Understudied Groups

Michael O'Riordan

May 09, 2023

News Conference News ACC 2023

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Michael O'Riordan

March 13, 2023

Advertisement

Periprocedural MI Signals Worse Outcomes in Stented NSTE ACS Patients: MATRIX

Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

The ‘Smoker’s Paradox’ Takes a New Hit From Long-term Analysis

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

Enough PCI ‘Versus’ CABG—Time to Focus on Understudied Groups

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content